Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Common Equity (2016 - 2025)

Healthy Extracts filings provide 11 years of Common Equity readings, the most recent being $24.0 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 5755.49% to $24.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.0 million, a 5755.49% increase, with the full-year FY2025 number at $24.0 million, up 5755.49% from a year prior.
  • Common Equity hit $24.0 million in Q4 2025 for Healthy Extracts, roughly flat from $24.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $24.1 million in Q3 2025 to a low of $60508.0 in Q1 2025.
  • Median Common Equity over the past 5 years was $1.2 million (2023), compared with a mean of $3.5 million.
  • Biggest five-year swings in Common Equity: plummeted 88.47% in 2024 and later skyrocketed 5755.49% in 2025.
  • Healthy Extracts' Common Equity stood at $2.5 million in 2021, then fell by 24.25% to $1.9 million in 2022, then crashed by 48.99% to $954590.0 in 2023, then crashed by 57.01% to $410377.0 in 2024, then skyrocketed by 5755.49% to $24.0 million in 2025.
  • The last three reported values for Common Equity were $24.0 million (Q4 2025), $24.1 million (Q3 2025), and $477958.0 (Q2 2025) per Business Quant data.